Skip to content

ENDS IN 9 MONTHS

Development Of Epetraborole As A Novel Therapeutic For Melioidosis And Additional Antimicrobial Resistant (…

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH NIAID

Open on USAspending ↗Look for the recompete on SAM.gov ↗
Sign in to track this contract

CAN YOU BID THIS?

Open competition

  • Last award was competed and not reserved for a program, so any eligible firm can bid.

Sign in and add a company profile to get a call for your firm.

Pro adds how many offers it drew last time to this read.

Check before you spend bid hours

  • Dates and values are from USAspending as of Oct 20, 2026. Confirm the incumbent's end date with the contracting office or a Sources Sought before committing bid hours.
Incumbent
AN2 THERAPEUTICS, INC
Small business · UEI DD4FE2GE4L78
Recompete expected (last option ends)
Jul 31, 2027
Current option period ends
Jul 31, 2027
Potential value
$18.3M ($9.2M obligated)
NAICS
541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
PSC
AN12 · Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Vehicle
Standalone contract
Award type
Definitive Contract
Place of performance
CA
Solicitation ID
PHS-2021-1
PIID
75N93022C00059

Last competition, subcontractors and incumbent

See how many offers this contract drew last time, who the incumbent subcontracts to, and the rest of the incumbent's expiring portfolio.

Unlock with Pro — $39 / mo

The buying office on SAM.gov

From notices this office (75N930) posted on SAM.gov in the last 12 months. Contacts are the duty points of contact published on those notices. All recompetes and contacts for this office →

Possibly already moving: 1 notice from this office may be this recompete. Open each one to confirm.

Pro emails you when a notice like these appears for a contract you track.

Recent notices from this office (1)

More expiring contracts from this office

Source: USAspending.gov prime award summary (FPDS), last modified Aug 18, 2026. Periods of performance change when options are exercised or the contract is modified; confirm on the source record before acting.